Alfresa Holdings Corporation

Tokyo Stock Exchange 2784.T

Alfresa Holdings Corporation Net Cash Used For Investing Activities for the year ending March 31, 2024: USD -93.93 M

Alfresa Holdings Corporation Net Cash Used For Investing Activities is USD -93.93 M for the year ending March 31, 2024, a 39.24% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Alfresa Holdings Corporation Net Cash Used For Investing Activities for the year ending March 31, 2023 was USD -154.60 M, a -916.79% change year over year.
  • Alfresa Holdings Corporation Net Cash Used For Investing Activities for the year ending March 31, 2022 was USD 18.93 M, a 144.30% change year over year.
  • Alfresa Holdings Corporation Net Cash Used For Investing Activities for the year ending March 31, 2021 was USD -42.73 M, a 73.01% change year over year.
  • Alfresa Holdings Corporation Net Cash Used For Investing Activities for the year ending March 31, 2020 was USD -158.31 M, a -35.57% change year over year.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
Loading...
Tokyo Stock Exchange: 2784.T

Alfresa Holdings Corporation

CEO Mr. Ryuji Arakawa
IPO Date Sept. 29, 2005
Location Japan
Headquarters 1-1-3 Otemachi
Employees 12,517
Sector Health Care
Industries
Description

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.

Similar companies

7459.T

MediPal Holdings Corporation

USD 14.64

-0.31%

4088.T

Air Water Inc.

USD 11.65

-2.49%

9987.T

Suzuken Co., Ltd.

USD 29.09

-1.76%

1812.T

Kajima Corporation

USD 16.70

-2.40%

4204.T

Sekisui Chemical Co., Ltd.

USD 15.85

-0.40%

StockViz Staff

January 16, 2025

Any question? Send us an email